InforMed looks at the phase 2 data, where the highest retatrutide dose reached 24.2% weight loss at 48 weeks, and weighs it against tirzepatide.
Recap by typeshit. Full story at InforMed.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
The weight loss drug class started with a lizard. A short local feature looks at how the Gila monster led researchers to GLP-1 medicines.
Healio
At the Cardiometabolic Health Congress, the UAB professor asked whether maximal weight loss is optimal and flagged that most non-diabetic patients quit GLP-1s within two years.
A short personal check-in from a creator who tags her post with tirzepatide. No numbers or details beyond the update itself.
12:13
Naivi walks through the symptoms she noticed, the fears she had going in and the results she saw over her first 14 days on tirzepatide.
Loading…